Pituitary Adenomas 2012
DOI: 10.5772/33824
|View full text |Cite
|
Sign up to set email alerts
|

Functioning Pituitary Adenoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 75 publications
0
5
0
Order By: Relevance
“…28,29 Functional macro-adenomas are associated with serious clinical manifestations in most cases, but non-functional types may have or not have this association. 30 Thus, differential diagnosis of both types is important in clinical evaluation or selection of therapeutic strategy. 4,5 DWI and low ADC values are suggested as the predictors of aggressive pituitary macro-adenoma.…”
Section: Discussionmentioning
confidence: 99%
“…28,29 Functional macro-adenomas are associated with serious clinical manifestations in most cases, but non-functional types may have or not have this association. 30 Thus, differential diagnosis of both types is important in clinical evaluation or selection of therapeutic strategy. 4,5 DWI and low ADC values are suggested as the predictors of aggressive pituitary macro-adenoma.…”
Section: Discussionmentioning
confidence: 99%
“…The tumors are often classified by secretory products they produce. Adrenocorticotropic hormone (ACTH) producing adenomas account for 10–20% of pituitary adenomas [1]. Typically, ACTH producing tumors of the pituitary gland result in Cushing’s disease, a process caused by excess glucocorticoid production [1].…”
Section: Introductionmentioning
confidence: 99%
“…Adrenocorticotropic hormone (ACTH) producing adenomas account for 10–20% of pituitary adenomas [1]. Typically, ACTH producing tumors of the pituitary gland result in Cushing’s disease, a process caused by excess glucocorticoid production [1]. The clinical manifestations of Cushing’s disease include central fat deposition, abdominal striae, moon facies, buffalo hump, osteoporosis, hypertension, hirsutism, gonadal dysfunction, and immunosuppression [1].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[ 11 14 ] In addition, the relapse rate of FPAs has been reported to be 20% to 45% depending on various endocrine functions. [ 15 17 ] Radiotherapy (RT) is frequently used in patients with residual or recurrent PAs with excellent rates of tumor control and remission of hormonal hypersecretion. Compared with conventional RT, CyberKnife stereotactic radiosurgery (CK SRS) allows for the delivery of a high dose of irradiation to the tumor while sparing critical radiosensitive structures, and it is widely used as postoperative adjuvant treatment of PAs.…”
Section: Introductionmentioning
confidence: 99%